(Q61969475)
Statements
Phase II Study of Continuation of Tyrosine Kinase Inhibitor (TKI) With or Without Chemotherapy Beyond Gradual Progression in Advanced Non-small Cell Lung Cancer (NSCLC) (English)
0 references
December 2013
0 references
June 2015
0 references
20
0 references
18 year
0 references
75 year
0 references